rheumatoid arthritis

Showing 6 posts of 66 posts found.

GSK expands inflammatory alliance

March 12, 2010
Research and Development Cellzome, GlaxoSmithKline, rheumatoid arthritis

GlaxoSmithKline has formed a second strategic alliance with Cellzome to research new treatments for inflammatory diseases. GSK will buy into …

Rheumatoid arthritis

Roche halts ocrelizumab trials

March 8, 2010
Research and Development RoActemra, ocrelizumab, rheumatoid arthritis

The future of Roche and Biogen Idec’s rheumatoid arthritis drug ocrelizumab has been thrown into doubt after the manufacturers decided …

AstraZeneca signs deal with Rigel on RA treatment

February 17, 2010
Research and Development AZ, Rigel, rheumatoid arthritis

AstraZeneca is looking to enter the lucrative rheumatoid arthritis market by in-licensing a phase II treatment.The global market for rheumatoid …


Orencia wins expanded European licence

January 27, 2010
Sales and Marketing BMS, Orencia, rheumatoid arthritis

BMS’s Orencia has been approved in Europe to treat children aged six and over who suffer from a form of …

Patient access scheme secures NICE approval for Cimzia

January 22, 2010
Sales and Marketing Cimzia, NICE, UCB, rheumatoid arthritis

UCB Pharma’s Cimzia has been recommended by NICE to treat rheumatoid arthritis – but only if a patient access scheme …

FDA approves Roche’s Actemra

January 11, 2010
Sales and Marketing Actemra, RoActemra, Roche, US, rheumatoid arthritis

Roche’s Actemra has been approved in the US for the treatment of moderately to severely active rheumatoid arthritis (RA) and …

Latest content